Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a <i>Post Hoc</i> Analysis of the PRODIGE-GERCOR IDEA-France TrialJulien Taieb, Valérie Taly, Julie Henriques, et al.
Autophagy|October 29, 2015
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancerSylvain Ladoire, Frédérique Penault-Llorca, Laura Senovilla, et al.
Cancer Research|November 8, 2013
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggeringAna I Romero, Nathalie Chaput, Vichnou Poirier-Colame, et al.
The EMBO Journal|January 15, 2015
Unsaturated fatty acids induce non-canonical autophagyMireia Niso-Santano, Shoaib Ahmad Malik, Federico Pietrocola, et al.
Science Translational Medicine|July 26, 2013
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndromeSylvie Rusakiewicz, Gaetane Nocturne, Thierry Lazure, et al.
Cancer Research|April 18, 2013
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumorsSylvie Rusakiewicz, Michaela Semeraro, Matthieu Sarabi, et al.
Nature Medicine|May 10, 2011
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNicolas F Delahaye, Sylvie Rusakiewicz, Isabelle Martins, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Oncoimmunology|February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patientsSylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
Nature Medicine|October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapyAntonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Pageof 3